make life lively Meiji

Meiji Holdings Co., Ltd.

Contact Us

Japanese

  • about us

    About Us

    • Who We Are
    • President's Message
    • Mission and Vision
    • Corporate Profile
    • History
    • R&D
      Food and Nutrition
      Pharmaceuticals
    • Quality
      Food and Nutrition
      Pharmaceuticals
  • products

    Products

    • Lineup
      Drinking Milk
      Yogurt
      Functional Yogurt
      Cheese
      Ice Cream
      Chocolate
      Whey Protein
      Infant Formula
      Beauty Supplement
      Enteral Formula and Nutritional Products
      Ethical Pharmaceuticals
      Agricultural Chemicals and Veterinary Drugs
    • Meiji Worldwide
      Meiji worldwide
  • investors

    Investors

    • 2019 Review
    • Our Businesses
    • Financial Performance
    • Business Plans
      2020 Medium-Term Business Plan
    • Governance
      Annual General Meeting
      Corporate Governance
      Business Risks
    • Results and Presentations
      Results
      Presentations
      DATA BOOK
      Integrated Reports
      R&D Pipeline
    • Stock Information
      Dividends
      Corporate Bonds and Ratings
      Analyst Coverage
    • M&A and Alliances
    • Investor FAQs
    • Disclosure Policy
    • Events
      Events Archive
    • ESG Data
  • sustainability

    Sustainability

    • Meiji Group Sustainability
      Top Commitment
      Sustainability Management
      Sustainability Video
    • Healthier Lives
      Health and Nutrition
      Quality and Safety
    • Caring for the Earth
      Environmental Management
      Climate Change
      Circular Economy
      Water
      Biodiversity
    • A Richer Society
      Human Resources
      Society
    • Sustainable Procurement
    • Governance
      Corporate Governance
      Compliance
      Risk Management
    • Policies
    • Download Report
    • UN Agencies
    • ESG Data
    • Standard Table
  • news
  • home
  • news
  • 2020

News

Jan 9, 2020
PHARMA Meiji and HUYABIO Enter into Exclusive Distribution, License and Collaboration Agreement of HBI-8000 for ATLL and PTCL Treatment in Japan and Certain Asian Countries
Jan 7, 2020
HD We updated Standard Table
Jan 7, 2020
PHARMA Meiji Seika Pharma and Kadmon Enter into Strategic Partnership to Develop and Commercialize KD025 for GVHD treatment in Japan and Asian Countries
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009

Back To Top

share

  • share
  • share
  • share

print

Worldwide Locations

Copyright Meiji Holdings Co., Ltd. All rights reserved.

  • Privacy Policy
  • Terms and Conditions